NumFin

Standard BioTools Inc.

符号: LAB

NASDAQ

2.41

USD

今天的市场价格

  • -2.5738

    市盈率

  • -0.0737

    PEG比率

  • 923.15M

    MRK市值

  • 0.00%

    DIV收益率

Standard BioTools Inc. (LAB) 财务报表

Download
年度季度
线性对数
在图表中，您可以看到 的动态默认数字 Standard BioTools Inc. (LAB). 的默认数据。公司收入显示 NaN M 的平均值，即 NaN % 增长率。整个期间的平均毛利润为 NaN M，即 NaN %. 平均毛利率为 NaN %. 公司去年的净收入增长率为 NaN %，等于 NaN % % 整个公司历史的平均增长率.,

年度季度
10Y20Y30Y40Y

资产负债表

深入分析 Standard BioTools Inc. 的财务轨迹，我们可以看到其平均资产增长率。有趣的是，这一增长率为 ，反映了公司的高点和低点。与季度相比，这一数字调整为. 回顾过去一年，总资产变化为 NaN. 股东权益总额所体现的股东价值是以报告货币计算的 NaN. 这方面的年同比变化率为 NaN%.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008200720062001

balance-sheet.row.cash-and-short-term-investments

0114.9165.828.5
68.5
58.6
95.4
63.1
59.4
95
115.3
84.3
80
53.5
5.7
14.6
17.8
40.4
25.5
0

balance-sheet.row.short-term-investments

063.284.50
0
37
0
5.1
24.4
65.9
81.6
49.1
21.4
39.9
0
0
0
6.3
0.5
0

balance-sheet.row.net-receivables

019.717.318.3
25.4
19
16.7
15
14.6
25.5
22.4
10.6
12.9
9.3
8.1
8.7
4.7
1.9
1.8
0

balance-sheet.row.inventory

020.521.520.8
19.7
13.9
13
15.1
20.1
17.9
16
8.1
7.2
6
4.9
3.9
5.5
5.5
3
0

balance-sheet.row.other-current-assets

03.14.34.5
4
4.6
2.1
1.5
2.5
5.7
2.2
1.5
1.1
1.3
2.2
1.2
1.3
2.6
0.8
0

balance-sheet.row.total-current-assets

0158.2208.872.1
117.7
96.1
127.1
94.8
96.7
144.1
155.9
104.6
101.2
70
20.9
28.5
29.2
50.3
31.1
0

balance-sheet.row.property-plant-equipment-net

054.959.565.2
55.6
12.9
8.8
12.3
16.5
15.3
13.9
6.8
5
3.3
2.3
1.9
2.8
3.4
4.1
0

balance-sheet.row.goodwill

0106.3106.3106.4
106.6
104.1
104.1
104.1
104.1
104.1
104.1
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

01.412.627.9
40.2
46.2
57.4
68.6
79.8
91
102.2
0
0
0
0
0
0
0
0
0

balance-sheet.row.goodwill-and-intangible-assets

0107.7118.9134.3
146.8
150.3
161.5
172.7
183.9
195.2
206.3
0
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-investments

00.811
1
1
0
0
0
6.5
27.5
1.9
3.7
2.8
1.3
0
0
0
0
0

balance-sheet.row.tax-assets

00-1-1
-1
-1
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-non-current-assets

01.53.13.7
4.7
5.5
6.2
7.5
9.3
10.1
4
3.6
3.9
3.2
0.3
1.7
0.4
1.1
1.3
0

balance-sheet.row.total-non-current-assets

0164.9181.5203.1
207.1
168.7
176.5
192.6
209.7
227
251.7
12.3
12.5
9.3
3.9
3.7
3.1
4.4
5.4
0

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

0323.1390.3275.2
324.8
264.8
303.6
287.4
306.4
371.1
407.6
116.9
113.7
79.3
24.8
32.2
32.4
54.8
36.5
0

balance-sheet.row.account-payables

09.27.910.6
9.2
6.5
4
4.2
4
6.1
5.9
4.4
2.6
4
3.2
2.2
2.9
2.7
1.2
0

balance-sheet.row.short-term-debt

063.95.89.9
3
1.8
0
0
0
0
0
-0.7
0
8.9
7.7
3.5
1
3.8
3.5
0

balance-sheet.row.tax-payables

01.21.21.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-54.1

balance-sheet.row.long-term-debt-total

0496.9101.8
92.4
58.1
172.1
195.2
195
195.7
195.5
0
0
1.2
10.1
14.5
14.2
10.5
22.4
0

Deferred Revenue Non Current

014.318.224.1
29
8.2
6.3
5
4.3
4.4
4.4
1.9
1.2
0.7
0.4
0.3
0.3
0.8
0.8
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

020.615.313.6
28.6
12.7
22.1
19
16.4
14.6
16.5
10.9
7.2
5.2
6.3
0.6
3.2
2.4
1.5
0

balance-sheet.row.total-non-current-liabilities

050.5428.3131.1
131.5
78.4
193.9
222.9
223.7
226.1
227.8
2.5
1.5
2.3
195.5
198.6
182.2
173.5
135.5
0

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

030.437.840.6
41.2
6.2
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

0159.9471.8180.6
185.7
111.2
231.5
256.4
253.2
256.2
257.1
19.8
13.1
22.4
214
205.8
190.7
185.1
142.7
-54.1

balance-sheet.row.preferred-stock

0311.3311.30
0
0
0
0
0
0
0
0.7
0
79.3
1.1
0
0
0
0
0

balance-sheet.row.common-stock

00.10.10.1
0.1
0.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.retained-earnings

0-1000.8-926.1-736
-676.8
-623.6
-558.9
-500.2
-439.5
-363.5
-310.2
-257.3
-240.8
-221.8
-199.3
-182.4
-163.3
-133.8
-108.3
0

balance-sheet.row.accumulated-other-comprehensive-income-loss

0-2.2-1.9-0.9
0.1
-0.6
-0.7
-0.6
-0.8
-1.1
-0.8
-0.7
-0.8
-0.8
-0.8
-0.5
-0.6
-0.1
0
0

balance-sheet.row.other-total-stockholders-equity

0854.8535.2831.4
815.6
777.8
631.6
531.7
493.4
479.5
461.4
354.5
342.2
200.1
9.9
9.3
5.5
3.6
2.1
0

balance-sheet.row.total-stockholders-equity

0163.2-81.594.6
139.1
153.6
72.1
30.9
53.2
114.9
150.4
97.1
100.7
56.9
-189.2
-173.6
-158.3
-130.3
-106.2
0

balance-sheet.row.total-liabilities-and-stockholders-equity

0323.1390.3275.2
324.8
264.8
303.6
287.4
306.4
371.1
407.6
116.9
113.7
79.3
24.8
32.2
32.4
54.8
36.5
0

balance-sheet.row.minority-interest

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-equity

0163.2-81.594.6
139.1
153.6
72.1
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

06484.51
1
37
0
5.1
24.4
72.3
109.1
51
25
42.8
1.3
0
0
6.3
0.5
0

balance-sheet.row.total-debt

098.2102.7111.6
95.4
60
172.1
195.2
195
195.7
195.5
0
0
10.1
17.8
14.5
15.2
14.4
25.9
0

balance-sheet.row.net-debt

046.521.383.2
26.9
38.3
76.7
137.2
159.9
166.6
161.7
-35.3
-58.6
-3.4
12.1
-0.1
-2.6
-19.7
0.9
0

现金流量表

在 Standard BioTools Inc. 的财务状况中，自由现金流在过去一段时间内发生了显著变化，呈现出 NaN 的转变。该公司最近通过发行 NaN 扩大了股本，与上一年相比出现了NaN 的差异. 公司的投资活动产生了现金使用净额，按报告货币计算达到NaN. 与上一年相比， NaN 发生了变化. 在同一时期，公司记录了 NaN, NaN 和 NaN，这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为NaN，同比差异为NaN. 此外，公司还将NaN 用于向股东分红。与此同时，该公司还采取了其他财务措施，即 NaN，这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起，全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008200720062001

cash-flows.row.net-income

0-74.7-190.1-59.2
-53
-64.8
-59
-60.5
-76
-53.3
-52.8
-15.8
-19
-22.5
-16.9
-19.1
-29.5
-25.5
-23.6
-59.2

cash-flows.row.depreciation-and-amortization

015.21515.6
15.9
15.8
16.6
18.6
17.9
16.1
4.1
2.6
1.5
1.1
1.5
1.9
2
2.1
1.5
11.9

cash-flows.row.deferred-income-tax

06.300
0.2
12.6
0.1
0
0
-2.3
-0.3
-1.8
0
23.4
0
-1.9
0
0
0
4.3

cash-flows.row.stock-based-compensation

013.114.916.1
14.5
11.4
11
9.1
13.9
16.8
20.9
6.4
4.1
2.8
1.6
2.1
2
0.7
0.1
4.9

cash-flows.row.change-in-working-capital

01.8-15.5-19.9
2.4
-13.2
-2.5
9.2
4.8
-8.2
-7.8
6.7
-4.1
-1
1.9
-2.7
-2.5
0.5
-1.2
49.7

cash-flows.row.account-receivables

0-31.16.7
-7.6
-2.1
-1.8
-0.6
10.5
-2.8
-3.4
2.4
-3.7
-1.2
0.2
-4
-3.3
-0.1
-0.4
18.3

cash-flows.row.inventory

0-4.9-8.5-4.8
-8.6
-2.7
1.5
4.6
-3.4
-3.7
-6.2
-1.5
-1.7
-1.1
-1
1.5
0
-2.5
-1
20.8

cash-flows.row.account-payables

01.6-2.81.3
3.4
2.1
-0.3
0.6
-2.3
0.8
0.1
1.8
-1.8
0.5
0.9
-0.6
0.1
1.5
-0.6
10.6

cash-flows.row.other-working-capital

08.1-5.3-23.2
15.3
-10.6
-1.9
4.6
-0.1
-2.5
1.6
4
3.1
0.8
1.7
0.5
0.7
1.6
0.7
-49.7

cash-flows.row.other-non-cash-items

0-586.33.4
4.6
3.1
8.6
-0.5
0.3
-3.8
13.4
0.3
0.1
-21.3
0.4
0.1
-0.8
0.3
0.8
-55.7

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-2.8-3.8-13.3
-12.7
-2.5
-0.4
-1.6
-5.1
-10.7
-7.4
-4.7
-2.4
-1.7
-1.5
-0.8
-0.9
-1
-2.9
-13.3

cash-flows.row.acquisitions-net

0084.30
-5.2
36.8
0
0.1
2.3
-2.3
-112.9
3.1
-14
0
0
0
0
0
0
0

cash-flows.row.purchases-of-investments

0-94.9-137.30
0
-62.4
-1.4
-6.3
-38.6
-67
-132.6
-59.4
-35.4
-71.4
0
0
-4.5
-6.3
-2
0

cash-flows.row.sales-maturities-of-investments

0118530
36.8
25.6
6.5
25.6
86.4
103.4
74.5
33.4
51.8
30
0
0
10.8
0.5
2
0

cash-flows.row.other-investing-activites

00-84.31.3
21
-36.8
0
-0.1
0
2.3
0
0
14
-2
0.2
0.1
0.6
0
0
1.3

cash-flows.row.net-cash-used-for-investing-activites

020.2-88.1-11.9
40
-39.3
4.7
17.7
45.1
25.7
-178.4
-27.6
14
-45.1
-1.3
-0.7
6
-6.7
-2.9
-11.9

cash-flows.row.debt-repayment

0-2.1-6.8-0.5
0
-51.8
0
0
0
0
0
0
-12.1
-12.9
0
-1
-3.9
-3.5
-4
0

cash-flows.row.common-stock-issued

00.82251.5
20.2
2.1
59.5
29
0.1
0
78.2
0
56
76.9
7.4
0
0
0
0
0

cash-flows.row.common-stock-repurchased

0-5.4-0.6-1.8
-0.5
-0.6
0
0
0
0
0
0
0
0
0
0
0
0
-0.1
0

cash-flows.row.dividends-paid

000-0.3
0
-1.5
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-financing-activites

0-0.113.217.1
1.1
54.6
-1.8
0
0
5.3
122.1
5.8
4.6
6.3
-3.6
18
10.2
41.1
35.2
16

cash-flows.row.net-cash-used-provided-by-financing-activities

0-6.8230.816
20.9
2.8
57.7
29
0.1
5.3
200.3
5.8
48.5
70.4
3.8
16.9
6.3
37.6
31.1
16

cash-flows.row.effect-of-forex-changes-on-cash

00-0.40
0.4
0.1
0.2
0.5
-0.2
-0.9
-0.9
0
0.1
0.1
0.2
0.1
0.1
0
0
0

cash-flows.row.net-change-in-cash

0-29.652.9-40.1
45.8
-71.7
37.3
23
5.9
-4.6
-1.5
-23.4
45.1
7.8
-8.9
-3.2
-16.3
9.1
5.9
-40.1

cash-flows.row.cash-at-end-of-period

051.782.329.5
69.5
23.7
95.4
58.1
35
29.1
33.7
35.3
58.6
13.6
5.7
14.6
17.8
34.1
25
29.5

cash-flows.row.cash-at-beginning-of-period

081.329.569.5
23.7
95.4
58.1
35
29.1
33.7
35.3
58.6
13.6
5.7
14.6
17.8
34.1
25
19.2
69.5

cash-flows.row.operating-cash-flow

0-43.3-89.4-44.1
-15.4
-35.2
-25.2
-24.1
-39.1
-34.7
-22.6
-1.6
-17.5
-17.5
-11.5
-19.5
-28.7
-21.8
-22.3
-44.1

cash-flows.row.capital-expenditure

0-2.8-3.8-13.3
-12.7
-2.5
-0.4
-1.6
-5.1
-10.7
-7.4
-4.7
-2.4
-1.7
-1.5
-0.8
-0.9
-1
-2.9
-13.3

cash-flows.row.free-cash-flow

0-46.1-93.2-57.3
-28.1
-37.7
-25.6
-25.7
-44.2
-45.3
-30
-6.3
-19.9
-19.2
-13
-20.3
-29.6
-22.7
-25.2
-57.3

利润表行

Standard BioTools Inc. 的收入与上期相比变化了 NaN%。据报告, LAB 的毛利润为 NaN。该公司的营业费用为 NaN，与上年相比变化了 NaN%. 折旧和摊销费用为 NaN，与上一会计期间相比变化了 NaN%. 营业费用报告为 NaN，显示NaN% 的同比变化。 销售和营销费用为 NaN, 其中 NaN% 与上年相比发生了变化。 基于近期数据的EBITDA为 NaN，同比增长NaN%. 营业收入为 NaN，与上年相比变化了NaN%. 净利润的变化率为 NaN%。去年的净收入为NaN.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008200720062001

income-statement-row.row.total-revenue

0106.397.9130.6
138.1
117.2
113
101.9
104.4
114.7
116.5
71.2
52.3
42.9
33.6
25.4
15.3
7.3
6.4
130.6

income-statement-row.row.cost-of-revenue

055.960.961.2
54.8
53
51.3
50
46
46.6
42.8
20.1
15.3
13.2
11.6
11.5
8.4
3.5
2.8
53.3

income-statement-row.row.gross-profit

050.537.169.4
83.3
64.3
61.6
52
58.4
68.1
73.6
51.1
37
29.7
22
13.9
7
3.8
3.6
77.3

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

07-12.37.6
0.5
1.4
0.6
0.4
-1.2
-1.2
-0.9
0.5
-0.2
0
0
0
0
0
0
7.9

income-statement-row.row.operating-expenses

0113.5153.3136.8
134.4
116.1
109.8
110.3
131.6
122.2
114.7
67.8
55.1
45.2
36.6
32
36.5
27.3
25.3
144.7

income-statement-row.row.cost-and-expenses

0169.4214.2198
189.2
169.1
161.1
160.3
177.6
168.9
157.6
87.9
70.4
58.4
48.1
43.4
44.9
30.8
28.1
198

income-statement-row.row.interest-income

004.30.3
0.3
1.3
0
0
0
0
0
0
0
0
0
0
0.8
1.1
0.6
0

income-statement-row.row.interest-expense

04.64.33.8
3.6
4.3
13.9
5.8
5.8
5.8
5.3
0
0.6
3.1
2.2
2.9
2
2.8
2.3
-3.8

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0-11.2-76.73.8
-3.1
-14.9
0.6
0.4
-1.2
5.2
-11.2
1
-0.2
-3.6
-0.1
1.7
1.2
-0.2
-0.2
3.8

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

07-12.37.6
0.5
1.4
0.6
0.4
-1.2
-1.2
-0.9
0.5
-0.2
0
0
0
0
0
0
7.9

income-statement-row.row.total-operating-expenses

0-11.2-76.73.8
-3.1
-14.9
0.6
0.4
-1.2
5.2
-11.2
1
-0.2
-3.6
-0.1
1.7
1.2
-0.2
-0.2
3.8

income-statement-row.row.interest-expense

04.64.33.8
3.6
4.3
13.9
5.8
5.8
5.8
5.3
0
0.6
3.1
2.2
2.9
2
2.8
2.3
-3.8

income-statement-row.row.depreciation-and-amortization

015.22.723.2
16.4
17.2
16.6
18.6
17.9
16.1
4.1
2.6
1.5
1.1
1.5
1.9
2
2.1
1.5
0

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

0-63-116.2-67.5
-51
-51.8
-48.2
-58.4
-73.2
-50.2
-51.8
-17.9
-18.1
-18.6
-14.6
-18
-29.5
-23.5
-21.7
-67.5

income-statement-row.row.income-before-tax

0-74.2-192.9-63.7
-54.1
-66.7
-61.4
-63.8
-80.2
-54.8
-57.7
-15.7
-18.9
-22.3
-16.8
-19.2
-29.6
-25.3
-23.6
-63.7

income-statement-row.row.income-tax-expense

00.5-2.8-4.4
-1.1
-1.9
-2.4
-3.3
-4.2
-1.5
-4.9
0.1
0.1
0.2
0.1
-0.1
-0.1
0.1
0.2
-4.4

income-statement-row.row.net-income

0-74.7-190.1-59.2
-53
-64.8
-59
-60.5
-76
-53.3
-52.8
-15.8
-19
-22.5
-16.9
-19.1
-29.5
-25.5
-23.6
-59.2
类似股票
您可能还对以下内容感兴趣：
8225.HK
China Health Group Inc..
0.119 HKD
HKSE
RVTY
Revvity, Inc..
104.34 USD
NYSE
IDXX
IDEXX Laboratories, Inc..
500.82 USD
NASDAQ
8037.HK
China Biotech Services Holdings Limited.
0.305 HKD
HKSE
SHL.AX
Sonic Healthcare Limited.
26.655 AUD
ASX
DGX
Quest Diagnostics Incorporated.
138.16 USD
NYSE
QIA.DE
Qiagen N.V..
40.345 EUR
XETRA
300685.SZ
Amoy Diagnostics Co., Ltd..
20.57 CNY
SHZ
603259.SS
WuXi AppTec Co., Ltd..
44.6 CNY
SHH
GTG.AX
Genetic Technologies Limited.
0.13 AUD
ASX

常见问题

什么是 Standard BioTools Inc. (LAB) 总资产是多少？

Standard BioTools Inc. (LAB) 总资产为 323067000.000.

什么是企业年收入？

年收入为 N/A.

企业利润率是多少？

公司利润率为 0.472.

什么是公司自由现金流？

自由现金流为 -0.578.

什么是企业净利润率？

净利润率为 -0.702.

企业总收入是多少？

总收入为 -0.659.

什么是 Standard BioTools Inc. (LAB) 净利润？{{符号}}净利润（净收入）是多少？

净利润（净收入）为 -74656000.000.

公司总债务是多少？

债务总额为 98210000.000.

营业费用是多少？

运营支出为 113489000.000.

公司现金是多少？

企业现金为 0.000.